Mirae Asset Global Investments Co., Ltd. Solid Biosciences Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$2.1 - $3.42 $24,399 - $39,736	-11,619 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$2.31 - $4.43 $2,051 - $3,933	888 Added 8.28%	11,619 $28,000
Q4 2019 Feb 12, 2020	BUY	$2.82 - $12.9 $30,261 - $138,429	10,731 New	10,731 $47,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $36.5M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.